コンテンツへスキップ
Merck

524650

PBS Tablets

10 mM phosphate buffer, and 3 mM KCl, tablet, pH 7.4 at 25°C

別名:

PBS, Phosphate Buffered Saline Tablets

ログインで組織・契約価格をご覧ください。

サイズを選択してください

表示を変更する

この商品について

UNSPSC Code:
12161706
NACRES:
NA.25
テクニカルサービス
お困りのことがあれば、経験豊富なテクニカルサービスチームがお客様をサポートします。
お手伝いします


製品名

PBS Tablets, Dissolving one tablet of PBS buffer in 1 liter of deionized H2O yields 140 mM NaCl, 10 mM phosphate buffer, and 3 mM KCl, pH 7.4 at 25°C. Note: 1 each = 10 tablets.

Quality Level

form

tablet

manufacturer/tradename

Calbiochem®

storage condition

OK to freeze

shipped in

ambient

storage temp.

10-30°C

General description

Developed for use in immunoassay applications. Dissolving one tablet in 1 liter of deionized H2O yields 140 mM NaCl, 10 mM phosphate buffer, and 3 mM KCl, pH 7.4 at 25°C. Note: 1 each = 10 tablets.
Dissolving one tablet in 1 liter of deionized H2O yields 140 mM NaCl, 10 mM phosphate buffer, and 3 mM KCl, pH 7.4 at 25°C. Note: 1 each = 10 tablets.

Application

PBS Tablets have been used:
  • as a wash buffer and as a blocking agent during immunohistochemical staining
  • in indirect enzyme-linked immunosorbent assay (ELISA)and enzymatic degradation of polyethylene glycol (PEG)ylated fibrin hydrogels

Preparation Note

Dissolve one tablet in one liter dH₂O to yield 10 mM phosphate buffer, pH 7.4, 140 mM NaCl, 3 mM KCl.
Following reconstitution, store in the refrigerator (4°C) or filter sterilize and store at room temperature (20°C).

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Toxicity: Irritant (B)


Still not finding the right product?

Explore all of our products under


保管分類

13 - Non Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



試験成績書(COA)

製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする


資料

Antibody fragmentation with our pepsin digestion protocol for IgG antibody fragmentation and preparation of F(ab’).


Valentina Agnolon et al.
Scientific reports, 10(1), 3016-3016 (2020-02-23)
Circulating HER2 extracellular domain (HER2 ECD) levels were proposed as a surrogate for HER2 tissue expression to monitor breast cancer patients for early relapse or responses to standard or HER2-targeted therapies, such as the monoclonal antibody (mAb) trastuzumab. Currently, available commercial



グローバルトレードアイテム番号

カタログ番号GTIN
524650-1EACN07790788051105